Cezanne predicts progression and adjuvant TACE response in hepatocellular carcinoma

We have previously reported that Cezanne could be a prognostic biomarker for survival in hepatocellular carcinoma (HCC) patients. However, the role of Cezanne genes in HCC cells and its response to postoperative adjuvant transcatheter arterial chemoembolization (TACE) in HCC patients remains unknown...

全面介紹

Na minha lista:
書目詳細資料
發表在:Cell Death Dis
Main Authors: Wang, Jia-hong, Zhong, Xiao-ping, Zhang, Yong-fa, Wu, Xiao-liang, Li, Shao-hua, Jian, Pei-en, Ling, Yi-hong, Shi, Ming, Chen, Min-shan, Wei, Wei, Guo, Rong-ping
格式: Artigo
語言:Inglês
出版: Nature Publishing Group 2017
主題:
Original Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5636974/
https://ncbi.nlm.nih.gov/pubmed/28880268
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cddis.2017.428
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍